Next COVID monoclonal antibody axed by FDA: Omicron 2 evades Sotrovimab.
Our Approach
Our Pipeline
Investors
Team
Key Publications
Collaboration or Partnering
News
Contact
Next COVID monoclonal antibody axed by FDA: Omicron 2 evades Sotrovimab.